Start for free
Start for free
C

Chione

Europe, Berlin, Germany, Berlin

Description

Chione is an investment company that aims to finance companies in the biomedical sector.

Investor Profile

Chione has made 8 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Series B (38%)
  • Series A (25%)
  • Seed (13%)
  • Series D (13%)
  • Series C (13%)

Country Focus

  • United States (50%)
  • Israel (25%)
  • Germany (13%)
  • Finland (13%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Hospital
  • Medical Device
  • Infrastructure
  • Machine Learning
  • Power Grid
  • Railroad
  • Sensor
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Chione frequently co-invest with?

HBM Healthcare Investments
HBM Healthcare Investments
Europe, Zug, Switzerland, Zug
Co-Investments: 1
UL
Upstart Life Ventures
North America, Utah, United States, Salt Lake City
Co-Investments: 2
Kinled Holding
Kinled Holding
North America, New York, United States, New York
Co-Investments: 1
Domain Associates
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 1
InterWest Partners
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 1
HealthCor Partners
HealthCor Partners
North America, South Carolina, United States, Charleston
Co-Investments: 1
DI
Co-Investments: 1
Acorn Bioventures
Acorn Bioventures
North America, New York, United States, New York
Co-Investments: 1
Catalyst Health Ventures
Catalyst Health Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2

Which angels does Chione often collaborate with?

CK
Carolin Kebekus
Europe, Nordrhein-Westfalen, Germany, Bergisch Gladbach
Shared Deals: 1
TH
Thomas Hesse
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by Chione?

Prisma Photonics

Tel Aviv, Tel Aviv, Israel

Prisma Photonics keeps the most critical large-scale infrastructure running with its next-generation optical fiber sensing solutions.

InfrastructureMachine LearningPower GridRailroadSensor
Series CSep 12, 2023
Amount Raised: $20,000,000
ICEYE

Espoo, Southern Finland, Finland

ICEYE is a Synthetic Aperture Radar (SAR) satellite imaging company that provides remote sensing capabilities.

AerospaceInformation TechnologyRemote SensingSatellite Communication
Series DFeb 3, 2022
Amount Raised: $136,000,000
Acrivon Therapeutics

Cambridge, Massachusetts, United States

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

BiotechnologyHealth CareOncologyTherapeutics
Series BNov 11, 2021
Amount Raised: $100,000,000
Prisma Photonics

Tel Aviv, Tel Aviv, Israel

Prisma Photonics keeps the most critical large-scale infrastructure running with its next-generation optical fiber sensing solutions.

InfrastructureMachine LearningPower GridRailroadSensor
Series AJan 1, 2020
Amount Raised: $10,000,000
Stagelink

Berlin, Berlin, Germany

Stagelink is a digital advertising and marketing company.

AdvertisingDigital MarketingMarketing AutomationSocial Media AdvertisingSocial Media Marketing
SeedMay 20, 2016
Sera Prognostics

Salt Lake City, Utah, United States

Sera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia, and other pregnancy complications.

BiotechnologyHealth CareHospitalMedicalMedical Device
Series BJan 7, 2015
Amount Raised: $20,000,000
Sera Prognostics

Salt Lake City, Utah, United States

Sera Prognostics develops blood tests that are predictive of preterm birth, preeclampsia, and other pregnancy complications.

BiotechnologyHealth CareHospitalMedicalMedical Device
Series BNov 18, 2014
Amount Raised: $5,000,000
Karyopharm Therapeutics

Newton, Massachusetts, United States

Karyopharm Therapeutics is a clinical-stage pharmaceutical company developing drugs for the treatment of cancer and other major diseases.

Health CareMedicalPharmaceutical
Series ANov 2, 2011
Amount Raised: $10,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator